BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 29133646)

  • 1. Efficacy of 1% atropine eye drops in retarding progressive axial myopia in Indian eyes.
    Kothari M; Rathod V
    Indian J Ophthalmol; 2017 Nov; 65(11):1178-1181. PubMed ID: 29133646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for progressive myopia in the atropine therapy for myopia study.
    Loh KL; Lu Q; Tan D; Chia A
    Am J Ophthalmol; 2015 May; 159(5):945-9. PubMed ID: 25640408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atropine for the treatment of childhood myopia: effect on myopia progression after cessation of atropine.
    Tong L; Huang XL; Koh AL; Zhang X; Tan DT; Chua WH
    Ophthalmology; 2009 Mar; 116(3):572-9. PubMed ID: 19167081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control.
    Yam JC; Jiang Y; Tang SM; Law AKP; Chan JJ; Wong E; Ko ST; Young AL; Tham CC; Chen LJ; Pang CP
    Ophthalmology; 2019 Jan; 126(1):113-124. PubMed ID: 30514630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of low-dose atropine on myopia progression, pupil diameter and accommodative amplitude: low-dose atropine and myopia progression.
    Fu A; Stapleton F; Wei L; Wang W; Zhao B; Watt K; Ji N; Lyu Y
    Br J Ophthalmol; 2020 Nov; 104(11):1535-1541. PubMed ID: 32086237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical atropine in retarding myopic progression and axial length growth in children with moderate to severe myopia: a pilot study.
    Fan DS; Lam DS; Chan CK; Fan AH; Cheung EY; Rao SK
    Jpn J Ophthalmol; 2007; 51(1):27-33. PubMed ID: 17295137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose (0.01%) atropine eye-drops to reduce progression of myopia in children: a multicentre placebo-controlled randomised trial in the UK (CHAMP-UK)-study protocol.
    Azuara-Blanco A; Logan N; Strang N; Saunders K; Allen PM; Weir R; Doherty P; Adams C; Gardner E; Hogg R; McFarland M; Preston J; Verghis R; Loughman JJ; Flitcroft I; Mackey DA; Lee SS; Hammond C; Congdon N; Clarke M
    Br J Ophthalmol; 2020 Jul; 104(7):950-955. PubMed ID: 31653669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2).
    Chia A; Chua WH; Cheung YB; Wong WL; Lingham A; Fong A; Tan D
    Ophthalmology; 2012 Feb; 119(2):347-54. PubMed ID: 21963266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Changes in Refraction and Biometry of Atropine- and Placebo-Treated Eyes.
    Kumaran A; Htoon HM; Tan D; Chia A
    Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5650-5. PubMed ID: 26313301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study: Phase 2 Report.
    Yam JC; Li FF; Zhang X; Tang SM; Yip BHK; Kam KW; Ko ST; Young AL; Tham CC; Chen LJ; Pang CP
    Ophthalmology; 2020 Jul; 127(7):910-919. PubMed ID: 32019700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Low-Concentration Atropine Eye Drops in Controlling the Progression of Myopia in Children: A One- and Two-Year Follow-Up Study.
    Zhang H; Yang P; Li Y; Zhang W; Li S
    Ophthalmic Epidemiol; 2024 Jun; 31(3):240-248. PubMed ID: 37528608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of myopia onset with 0.025% atropine in premyopic children.
    Fang PC; Chung MY; Yu HJ; Wu PC
    J Ocul Pharmacol Ther; 2010 Aug; 26(4):341-5. PubMed ID: 20698798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Efficacy of Low-Dose Atropine Eyedrops for the Treatment of Myopia Progression in Chinese Children: A Randomized Clinical Trial.
    Wei S; Li SM; An W; Du J; Liang X; Sun Y; Zhang D; Tian J; Wang N
    JAMA Ophthalmol; 2020 Nov; 138(11):1178-1184. PubMed ID: 33001210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five-year results of atropine 0.01% efficacy in the myopia control in a European population.
    Moriche-Carretero M; Revilla-Amores R; Gutiérrez-Blanco A; Moreno-Morillo FJ; Martinez-Perez C; Sánchez-Tena MÁ; Alvarez-Peregrina C
    Br J Ophthalmol; 2024 May; 108(5):715-719. PubMed ID: 37268328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additive effects of orthokeratology and atropine 0.01% ophthalmic solution in slowing axial elongation in children with myopia: first year results.
    Kinoshita N; Konno Y; Hamada N; Kanda Y; Shimmura-Tomita M; Kakehashi A
    Jpn J Ophthalmol; 2018 Sep; 62(5):544-553. PubMed ID: 29974278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atropine for the treatment of childhood myopia: changes after stopping atropine 0.01%, 0.1% and 0.5%.
    Chia A; Chua WH; Wen L; Fong A; Goon YY; Tan D
    Am J Ophthalmol; 2014 Feb; 157(2):451-457.e1. PubMed ID: 24315293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control: A Randomized Clinical Trial.
    Repka MX; Weise KK; Chandler DL; Wu R; Melia BM; Manny RE; Kehler LAF; Jordan CO; Raghuram A; Summers AI; Lee KA; Petersen DB; Erzurum SA; Pang Y; Lenhart PD; Ticho BH; Beck RW; Kraker RT; Holmes JM; Cotter SA;
    JAMA Ophthalmol; 2023 Aug; 141(8):756-765. PubMed ID: 37440213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy Comparison of 16 Interventions for Myopia Control in Children: A Network Meta-analysis.
    Huang J; Wen D; Wang Q; McAlinden C; Flitcroft I; Chen H; Saw SM; Chen H; Bao F; Zhao Y; Hu L; Li X; Gao R; Lu W; Du Y; Jinag Z; Yu A; Lian H; Jiang Q; Yu Y; Qu J
    Ophthalmology; 2016 Apr; 123(4):697-708. PubMed ID: 26826749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Effects on Ocular Biometrics by 0.05%, 0.025%, and 0.01% Atropine: Low-Concentration Atropine for Myopia Progression Study.
    Li FF; Kam KW; Zhang Y; Tang SM; Young AL; Chen LJ; Tham CC; Pang CP; Yam JC
    Ophthalmology; 2020 Dec; 127(12):1603-1611. PubMed ID: 32525048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Atropine 0.01% Eye Drops on the Difference in Refraction and Axial Length between Right and Left Eyes.
    Liang X; Wei S; Li SM; An W; Du J; Sun Y; Gan J; Bai W; Cai Z; Song Q; Yin L; Wang N
    Ophthalmic Res; 2023; 66(1):496-505. PubMed ID: 36603556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.